PTK7 (Protein Tyrosine Kinase 7) Gene: Function, Mutations, and Disease Associations

Comprehensive biomedical overview of PTK7, a pseudokinase involved in Wnt signaling, cell polarity, and cancer progression.

Gene Information Card

Symbol PTK7
Full Name Protein tyrosine kinase 7 (inactive)
Gene Type protein-coding
Chromosomal Location 6p21.1
NCBI Gene ID 5754 ncbi.nlm.nih.gov/gene/5754
Ensembl ID ENSG00000112655
UniProt ID Q13308
OMIM ID 601890
HGNC ID 9618
Aliases CCK4, CCK-4, FLJ14490, MGC138236

Description

PTK7 (protein tyrosine kinase 7) is a catalytically inactive receptor tyrosine kinase (pseudokinase) that functions as a coreceptor in the Wnt/planar cell polarity (PCP) signaling pathway. It plays critical roles in cell migration, polarity, and tissue morphogenesis. PTK7 is implicated in neural tube defects and multiple cancers, including colorectal, lung, and breast cancer, where it can act as an oncogene or tumor suppressor depending on context.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neural tube defects (e.g., spina bifida) Loss-of-function variants disrupt Wnt/PCP signaling, impairing neural tube closure. ClinVar, OMIM
Colorectal cancer PTK7 overexpression promotes Wnt/β-catenin signaling and tumor invasion. COSMIC, NCBI
Lung adenocarcinoma PTK7 upregulation correlates with poor prognosis and metastatic potential. COSMIC, PubMed
Breast cancer PTK7 expression is associated with aggressive subtypes and chemoresistance. COSMIC, PubMed
Acute myeloid leukemia (AML) PTK7 is a surface marker on leukemic stem cells; aberrant splicing variants detected. COSMIC, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Lung 8.3 Low
Colon 15.2 Medium
Breast 9.1 Low
Kidney 6.7 Low
Liver 4.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
HeLa (cervical) 18.5 High expression
A549 (lung) 22.1 High expression
MCF7 (breast) 14.3 Medium expression
HCT116 (colon) 20.7 High expression
K562 (leukemia) 8.9 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1450C>T (p.Arg484*) Nonsense <0.1% Loss of function; associated with neural tube defects
c.1123G>A (p.Gly375Arg) Missense <0.1% Unknown significance; reported in AML
c.1687_1688insA (p.Thr563Asnfs*2) Frameshift <0.1% Loss of function; neural tube defects
c.2012A>G (p.Asn671Ser) Missense 0.2% Gain of function?; observed in colorectal cancer
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg484*, p.Thr563Asnfs*2) truncate the protein, disrupting Wnt/PCP signaling and causing neural tube defects.

Gain of Function (GOF)

Missense variants such as p.Asn671Ser may enhance PTK7 stability or signaling, potentially promoting oncogenic Wnt/β-catenin activity in colorectal cancer.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported; however, truncated isoforms could interfere with wild-type PTK7 function.

Pathways

• Wnt/planar cell polarity (PCP) signaling
• Wnt/β-catenin signaling
• Cell migration and polarity pathways

Protein Summary

PTK7 is a 1070-amino-acid single-pass transmembrane protein with an extracellular immunoglobulin-like domain and an intracellular tyrosine kinase domain that lacks catalytic activity (pseudokinase). It acts as a coreceptor for Wnt ligands, modulating both canonical (β-catenin) and non-canonical (PCP) pathways. PTK7 is glycosylated and localized to the plasma membrane, where it regulates cell polarity, migration, and adhesion. Altered expression or mutation contributes to developmental disorders and cancer progression.

Related Products

Product name Cat.No. Species Gene ID
PTK7 Knockout HEK293 Cell Line EDJ-KQ17749 Human 5754 Details Get a Quote
PTK7 Knockout HeLa Cell Line EDJ-KQ18302 Human 5754 Details Get a Quote
PTK7 Knockout A-549 Cell Line EDJ-KQ19820 Human 5754 Details Get a Quote
PTK7 Knockout HCT 116 Cell Line EDJ-KQ19821 Human 5754 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: